Itau Unibanco Holding S.A.’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-135
Closed -$7.93K 390
2023
Q4
$7.93K Sell
135
-26
-16% -$1.46K ﹤0.01% 320
2023
Q3
$7.01K Hold
161
﹤0.01% 437
2023
Q2
$5.82K Sell
161
-25
-13% -$1.03K ﹤0.01% 485
2023
Q1
$6.92K Hold
186
﹤0.01% 467
2022
Q4
$8.43K Sell
186
-33
-15% -$2.14K ﹤0.01% 468
2022
Q3
$15K Hold
219
﹤0.01% 475
2022
Q2
$15K Buy
219
+4
+2% +$254 ﹤0.01% 408
2022
Q1
$18K Hold
215
﹤0.01% 392
2021
Q4
$32K Buy
215
+43
+25% +$6.68K ﹤0.01% 342
2021
Q3
$30K Buy
172
+4
+2% +$644 ﹤0.01% 310
2021
Q2
$27K Buy
+168
New +$27K ﹤0.01% 270

Other funds holding MRTX

Itau Unibanco Holding S.A.'s MRTX Position: Q1 2024 in Review

Itau Unibanco Holding S.A. sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 135 shares — an estimated $7.93K sold.

Itau Unibanco Holding S.A. first reported a position in MRTX in Q2 2021 and held it in 11 quarters. The position peaked at $32K in Q4 2021. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

  • Itau Unibanco Holding S.A. reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Itau Unibanco Holding S.A. sold 135 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $7.93K.
  • Itau Unibanco Holding S.A. first reported a position in Mirati Therapeutics, Inc. Common Stock in Q2 2021 and held it in 11 quarters.
  • Itau Unibanco Holding S.A.'s Mirati Therapeutics, Inc. Common Stock position peaked at $32K in Q4 2021.
  • 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q1 2024, filed 14 May 2024.